Clinical Trials Directory

Trials / Completed

CompletedNCT02708459

Transversus Abdominus Plane Block in Living Donor Hepatectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
AlRefaey Kandeel · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Comparing different drugs used in Transversus abdominus plane analgesia after donor hepatectomy. Patients will be divided into three groups; control group, Bupivecaine group, and Dexmedetomedine group according to the used drug

Detailed description

Transversus abdominus plane block for postoperative analgesia after donor hpatectomy surgery using three different drugs control group, Bupivecaine group, and Dexmedetomedine group

Conditions

Interventions

TypeNameDescription
DEVICEsurgically inserted Transversus abdominus plane catheterat end of surgery, a surgeon will insert catheter in Transversus abdominus plane (TAP) between internal oblique muscle and Transversus abdominus muscle
DRUGIntravenous morphineBoluses of intravenous morphine (2 mg) will be given to patients if Visual analogue scale (VAS) more than 3
DRUGBupevecaine
DRUGDexmedetomedine

Timeline

Start date
2016-03-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2016-03-15
Last updated
2016-08-30

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02708459. Inclusion in this directory is not an endorsement.